darunavir receives us fda approval
Post on 13-Dec-2016
213 Views
Preview:
TRANSCRIPT
Inpharma 1662 - 1 Nov 2008
■ Darunavir receives US FDA approval. TibotecTherapeutics has announced that darunavir [Prezista]has received US FDA approval for an expandedindication for once-daily dosing as part of HIVcombination therapy in treatment-naive adults. TheFDA also granted full approval to darunavir as twice-daily for use in treatment-experienced adult patients.Tibotec Therapeutics. U.S. Food and Drug Administration (FDA) ApprovesPREZISTA(R) Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1. Media Release : 22 Oct 2008. Available from:URL: http://www.tibotec.com 809094302
1
Inpharma 1 Nov 2008 No. 16621173-8324/10/1662-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
top related